On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Earth Science Tech, Inc. (ETST) Shares Progress on CBD Formulas

  • Continued progress on CBD patent formulas
  • Update on the development of three CBD formulas already under the provisory patent
  • Additional three products at various stages with Bionatus

Earth Science Tech, Inc. (OTC: ETST), a biotechnology company focused on cannabidiol (CBD), nutraceuticals, pharmaceuticals and medical devices, shared progress on its CBD patent formulas in a recent press release (http://cnw.fm/D0PLq). The company has three new CBD formulas under the provisory patent and three Bionatus products in various stages of development.

ETST is developing three CBD formulas already under the provisory patent whose function is to maintain quality of life and prevent inflammation, cancer and degenerative diseases. The company announced in March (http://cnw.fm/npJS5) that it had received a grant from the Government of Quebec earmarked for the pre-launch process of these three CBD-based nutraceutical provisional patent products.

Research and development has been very promising on the first two unique CBD formula products, a neuron protector and a breast protector. The final formulation is currently being developed to assure the longest possible shelf life using a yet to be determined natural protective agent. The third CBD formula is a unique superfood formulated from a mix of hemp oil and other vegetal oil(s), enriched with potent antioxidants and designed to improve antioxidant ingestion.

ETST has two products in development, Propovit and a reformulation of Bionatus, through a joint venture with Bionatus Laboratrio Botnico of Brazil and its Canadian division, Bionatus Botanical Laboratories, Inc.  Propovit is used to help alleviate throat irritation, colds and bad breath. The new formulation will be enriched with ETST hemp oil. The main natural ingredient in Bionatus is the Guaco extract. Traditional uses of this extract suppose anti-inflammatory and bronchial-dilation properties, properties that ETST and Bionatus believe will be enriched with the addition of CBD. A third product is also being planned by ETST and Bionatus, with details to be shared soon.

The company intends to share further updates on its CBD IP patent formulas as they progress.

For more information, visit the company’s website at www.EarthScienceTech.com

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Archives

Select A Month

Contact us: 303.498.7722